JointMedica receive Continuity Support Grant for current Innovate UK funded projects
JointMedica receive Continuity Support Grant for current Innovate UK funded projects
JointMedica are set to benefit from a Continuity Support package, providing businesses with help to support projects which have been delayed and affected by the COVID-19 pandemic.
Monies were made available in continuity grants to SMEs and third sector organisations who are existing Innovate UK award holders to ensure the success and delivery of new innovation during the COVID-19 epidemic.
Terence Smith, Managing Director of JointMedica commented;
We are eternally grateful to the innovate UK organisation for their continued support of our development technologies. JointMedica can now continue with our work, striving towards our goals.
For further information visit www.innovateuk.gov.uk
About Us
Jointmedica was formed in 2000.
Our pedigree can be traced back to 1997 when the first Birmingham Hip Resurfacings® were implanted.
We are a privately funded orthopaedic company that seeks to sympathetically enhance the currently accepted arthroplasty interventions, by creating implants which exhibit superior functionality, apply biomechanical sensitivity, and innovative form.
Principally we are an Orthopaedic Design and Development ‘Think Tank’, with the aim to progress and disseminate new ideas that result in the creation of innovative orthopaedic implants.
Our strategic intent is to facilitate early partnerships and acquisition opportunities of these concepts, at the point of commercial attractiveness, to established Orthopaedic Sales companies.
®Trademark of Smith & Nephew
